BioCentury | Jul 26, 2019
Preclinical News

July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more

...Israel). Cytokinetics’ CK-2066260 could improve muscle performance Researchers at Karolinska Institutet, Cytokinetics Inc (NASDAQ:CYTK) and University of Missouri...
BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

...treat hepatocellular carcinoma (HCC) and protect adoptively transferred effector T cells from tumor-induced immune tolerance University of Missouri...
BioCentury | Mar 28, 2019
Product Development

Striking a cord for microbiome regulation with a path for FMTs

...a gain, not a loss, for patients, said Erika Lietzan, associate professor of law at University of Missouri...
...Greenleaf Health, Washington, D.C. Ferring Pharmaceuticals A/S, Saint-Prex, Switzerland Seres Therapeutics Inc. (NASDAQ:MCRB), Cambridge, Mass. University of Missouri...
...Silver Spring, Md. Karen Tkach Tuzman, Associate Editor Ferring Pharmaceuticals A/S Seres Therapeutics Inc. U.S. Food and Drug Administration (FDA) University of Missouri microbiome...
BioCentury | Oct 3, 2018
Politics & Policy

Phage display founders win Nobel for chemistry

...million ($1 million) prize was shared by George Smith, who is a professor emeritus at University of Missouri...
BioCentury | Sep 9, 2017
Company News

Allergan partners with tribe to fight IPR

...be pierced as if a fraudulent corporate veil.” Crouch is an associate professor at the University of Missouri...
BioCentury | May 23, 2017
Regulation

Misalignment in autism

...told BioCentury. Beversdorf is an associate professor of radiology, neurology and psychological sciences at the University of Missouri...
...OTCQX:RHHBY), Basel, Switzerland Syracuse University, Syracuse, N.Y. University of California San Francisco, San Francisco, Calif. University of Missouri...
BioCentury | Apr 22, 2017
Politics, Policy & Law

Shall we dance?

...Sandoz offers only complications and uncertainty.” Erika Lietzan, an associate professor of law at the University of Missouri...
...Tel Aviv:MYL), Canonsburg, Pa. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Missouri...
BioCentury | Feb 12, 2015
Targets & Mechanisms

High five for Arsanis

...screening strategy can be applied more broadly. George Smith, professor of biological sciences at the University of Missouri...
...NYSE:AZN), London, U.K. Massachusetts Institute of Technology, Cambridge, Mass. Pfizer Inc. (NYSE:PFE), New York, N.Y. University of Missouri...
BioCentury | Jun 5, 2014
Distillery Techniques

Technology: Disease models

...5, 2014 Unpatented; pigs available from the National Swine Resource and Research Center at the University of Missouri...
...doi:10.1073/pnas.1406376111 Contact: Jin-Hoi Kim, Konkuk University, Seoul, South Korea e-mail: jhkim541@konkuk.ac.kr Contact: Randall S. Prather, University of Missouri...
BioCentury | Aug 30, 2012
Distillery Therapeutics

Indication: Cancer

...30, 2012 Provisional patent application filed; available for licensing from the University of Missouri-Columbia Contact: Paul Hippenmeyer, University of Missouri-Columbia...
...al. J. Med. Chem.; published online Aug. 13, 2012; doi:10.1021/jm300740t Contact: Mark W. Lee Jr., University of Missouri-Columbia...
Items per page:
1 - 10 of 48
BioCentury | Jul 26, 2019
Preclinical News

July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more

...Israel). Cytokinetics’ CK-2066260 could improve muscle performance Researchers at Karolinska Institutet, Cytokinetics Inc (NASDAQ:CYTK) and University of Missouri...
BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

...treat hepatocellular carcinoma (HCC) and protect adoptively transferred effector T cells from tumor-induced immune tolerance University of Missouri...
BioCentury | Mar 28, 2019
Product Development

Striking a cord for microbiome regulation with a path for FMTs

...a gain, not a loss, for patients, said Erika Lietzan, associate professor of law at University of Missouri...
...Greenleaf Health, Washington, D.C. Ferring Pharmaceuticals A/S, Saint-Prex, Switzerland Seres Therapeutics Inc. (NASDAQ:MCRB), Cambridge, Mass. University of Missouri...
...Silver Spring, Md. Karen Tkach Tuzman, Associate Editor Ferring Pharmaceuticals A/S Seres Therapeutics Inc. U.S. Food and Drug Administration (FDA) University of Missouri microbiome...
BioCentury | Oct 3, 2018
Politics & Policy

Phage display founders win Nobel for chemistry

...million ($1 million) prize was shared by George Smith, who is a professor emeritus at University of Missouri...
BioCentury | Sep 9, 2017
Company News

Allergan partners with tribe to fight IPR

...be pierced as if a fraudulent corporate veil.” Crouch is an associate professor at the University of Missouri...
BioCentury | May 23, 2017
Regulation

Misalignment in autism

...told BioCentury. Beversdorf is an associate professor of radiology, neurology and psychological sciences at the University of Missouri...
...OTCQX:RHHBY), Basel, Switzerland Syracuse University, Syracuse, N.Y. University of California San Francisco, San Francisco, Calif. University of Missouri...
BioCentury | Apr 22, 2017
Politics, Policy & Law

Shall we dance?

...Sandoz offers only complications and uncertainty.” Erika Lietzan, an associate professor of law at the University of Missouri...
...Tel Aviv:MYL), Canonsburg, Pa. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Missouri...
BioCentury | Feb 12, 2015
Targets & Mechanisms

High five for Arsanis

...screening strategy can be applied more broadly. George Smith, professor of biological sciences at the University of Missouri...
...NYSE:AZN), London, U.K. Massachusetts Institute of Technology, Cambridge, Mass. Pfizer Inc. (NYSE:PFE), New York, N.Y. University of Missouri...
BioCentury | Jun 5, 2014
Distillery Techniques

Technology: Disease models

...5, 2014 Unpatented; pigs available from the National Swine Resource and Research Center at the University of Missouri...
...doi:10.1073/pnas.1406376111 Contact: Jin-Hoi Kim, Konkuk University, Seoul, South Korea e-mail: jhkim541@konkuk.ac.kr Contact: Randall S. Prather, University of Missouri...
BioCentury | Aug 30, 2012
Distillery Therapeutics

Indication: Cancer

...30, 2012 Provisional patent application filed; available for licensing from the University of Missouri-Columbia Contact: Paul Hippenmeyer, University of Missouri-Columbia...
...al. J. Med. Chem.; published online Aug. 13, 2012; doi:10.1021/jm300740t Contact: Mark W. Lee Jr., University of Missouri-Columbia...
Items per page:
1 - 10 of 48